MedTrace Logo

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

NCT01034033 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3300

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.

Conditions

Sponsors & Collaborators

  • Stanford University

    lead OTHER

  • Breast Cancer Research Foundation

    collaborator OTHER

  • Susan G. Komen Breast Cancer Foundation

    collaborator OTHER

Principal Investigators

  • James M Ford · Stanford University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-08-31
Primary Completion
2099-01-31
Completion
2099-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01034033 on ClinicalTrials.gov